On June 12, 2015, Cimarron Medical, Inc., Sun BioPharma, Inc. and SB Acquisition Corporation entered into an agreement and plan of merger. Sun BioPharma, Inc. has appointed, and Parent hereby consents to the appointment of, Michael T. Cullen, Thomas X. Neenan, Paul W. Schaffer, and D. Robert Schemel to serve as new Board members as of the Merger Time.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4233 USD | +3.23% |
|
+3.27% | -97.69% |
17/05 | North American Morning Briefing : The "Everything -2- | DJ |
15/05 | Transcript : Panbela Therapeutics, Inc., Q1 2024 Earnings Call, May 15, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.69% | 1.99M | |
+38.30% | 53.67B | |
+33.67% | 38.86B | |
-8.06% | 38.76B | |
-10.77% | 27.27B | |
+11.28% | 25.91B | |
-15.77% | 20.29B | |
+33.94% | 12.78B | |
+28.06% | 12.18B | |
-2.75% | 11.96B |
- Stock Market
- Equities
- SNBP Stock
- News Panbela Therapeutics, Inc.
- Sun BioPharma, Inc. Announce Appointment of Board Members